Evidence map›Paper›PMID 32522469›Full record

ReviewSchizophrenia research2020

A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.

Gregory P Strauss, Andrea Pelletier-Baldelli, Katherine Frost Visser, Elaine F Walker, Vijay A Mittal

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Schizophrenia research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05398120 (Testing the Feasibility of a Skills Group for Adolescents and Young Adults at Clinical High-risk for Psychosis), which is not on this map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05398120 narecruitingnot on this mapstarted 2022, after this paper: background citation

Testing the Feasibility of a Skills Group for Adolescents and Young Adults at Clinical High-risk for Psychosis

TypeinterventionalSponsorUniversity of PittsburghRan2022 to 2026Enrolled30ConditionsClinical High-Risk, PsychologicalArmsSkills Group
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Gregory P StraussDepartment of Psychology, University of Georgia, Athens, GA, USA. Electronic address: gstrauss@uga.edu.
Andrea Pelletier-BaldelliDepartment of Psychiatry, University of North Carolina, Chapel Hill, NC, USA.
Katherine Frost VisserDepartment of Psychology, University of Georgia, Athens, GA, USA.
Elaine F WalkerDepartment of Psychology, Emory University, Atlanta, GA, USA.
Vijay A MittalDepartment of Psychology, Northwestern University, Evanston, IL, USA.
University of Georgia · USEmory University · USNorthwestern University · USUniversity of North Carolina at Chapel Hill · US

Funding

2/9 - Predictors and Mechanisms of Conversion to PsychosisU01MH081988 · NIMH · EMORY UNIVERSITY · PI WALKER, ELAINE FRAN · 2008 to 2018
$5.4M
Prodromal Inventory for Negative Symptoms (PINS): A Development and Validation StudyR01MH116039 · NIMH · UNIVERSITY OF GEORGIA · PI MITTAL, VIJAY A, STRAUSS, GREGORY P · 2019 to 2023
$3.1M
4/5 CAPER: Computerized assessment of psychosis riskR01MH120092 · NIMH · UNIVERSITY OF GEORGIA · PI STRAUSS, GREGORY P · 2020 to 2024
$2.0M
2/3 Community psychosis risk screening: An instrument development studyR01MH112545 · NIMH · NORTHWESTERN UNIVERSITY · PI MITTAL, VIJAY A · 2017 to 2021
$1.2M
Mechanisms Underlying Emotion Regulation Abnormalities in Youth at Clinical High-Risk for PsychosisR21MH119438 · NIMH · UNIVERSITY OF GEORGIA · PI STRAUSS, GREGORY P · 2019 to 2020
$415k
NIMH NIH HHS R01 MH112545NIMH NIH HHS R01 MH116039NIMH NIH HHS R01 MH120092NIMH NIH HHS R21 MH119438NIMH NIH HHS U01 MH081988
6 · The paper itself

Abstract

Studies attempting to deconstruct the heterogeneity of schizophrenia and the attenuated psychosis syndrome consistently find that negative symptoms are a core dimension that is distinct from other aspects of the illness (e.g., positive and disorganized symptoms). Negative symptoms are also highly predictive of poor community-based functional outcomes, suggesting they are a critical treatment target. Unfortunately, pharmacological and psychosocial treatments for negative symptoms have demonstrated limited effectiveness. To address this critical unmet therapeutic need, the NIMH sponsored a consensus development conference to delineate research priorities for the field and stimulate treatment development. A primary conclusion of this meeting was that next-generation negative symptom rating scales should be developed to address methodological and conceptual limitations of existing instruments. Although second-generation rating scales were developed for adults with schizophrenia, progress in this area has lagged behind for youth at clinical-high risk (CHR) for developing psychosis (i.e. those meeting criteria for a prodromal syndrome). Given that negative symptoms are highly predictive of the transition to diagnosable psychotic illness, enhancing our ability to detect negative symptoms in CHR youth is paramount. The current paper discusses conceptual and methodological limitations inherent to existing scales that assess negative symptoms in CHR youth. The theoretical and clinical implications of these limitations are evaluated. It is concluded that new scales specifically designed to assess negative symptoms in CHR youth are needed to accurately chart mental illness trajectories and determine when, where, and how to intervene. Recent efforts to develop next-generation measures designed specifically for CHR youth to meet this urgent need in the field are discussed. These new approaches offer significant progress for addressing issues inherent to earlier scales.

Indexed as

Psychotic DisordersSchizophreniaSymptom AssessmentAdolescentAdultHumansProdromal SymptomsPsychiatric Status Rating ScalesAlogiaAnhedoniaAsocialityAvolitionBlunted affectProdrome

Identifiers

PMID32522469
PMCPMC7572550
OpenAlexW3033456753

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.